A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study will evaluate thrice weekly dosing with vintafolide to find the maximum tolerable dose. The primary study hypothesis is that administration of vintafolide to participants with advanced solid tumors will have acceptable safety and tolerability.
Epistemonikos ID: 093841601c0e719c5228f388473cdf8514deb252
First added on: May 11, 2024